A negative binomial regression model for risk estimation of 0–2 axillary lymph node metastases in breast cancer patients

D Zeng, HY Lin, YL Zhang, JD Wu, K Lin, Y Xu… - Scientific Reports, 2020 - nature.com
Extensive clinical trials indicate that patients with negative sentinel lymph node biopsy do
not need axillary lymph node dissection (ALND). However, the ACOSOG Z0011 trial …

International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer

TJ Meretoja, MHK Leidenius, PS Heikkilä… - Journal of the …, 2012 - academic.oup.com
Background Axillary treatment of breast cancer patients is undergoing a paradigm shift, as
completion axillary lymph node dissections (ALNDs) are being questioned in the treatment …

International multicenter tool to predict the risk of four or more tumor-positive axillary lymph nodes in breast cancer patients with sentinel node macrometastases

TJ Meretoja, RA Audisio, PS Heikkilä, R Bori… - Breast cancer research …, 2013 - Springer
Recently, many centers have omitted routine axillary lymph node dissection (ALND) after
metastatic sentinel node biopsy in breast cancer due to a growing body of literature …

Three models for predicting the risk of non-sentinel lymph node metastasis in Japanese breast cancer patients

T Sasada, T Kataoka, H Shigematsu, N Masumoto… - Breast Cancer, 2014 - Springer
Background Axillary lymph node dissection (ALND) is the standard procedure for breast
cancer with sentinel lymph node (SLN) metastasis. However, additional nodal metastasis is …

Predicting the burden of axillary disease in breast cancer patients with a positive sentinel node.

B Unal, SA Gur, S Beriwal, R Johnson, G Ahrendt… - Cancer Research, 2009 - AACR
Abstract Abstract# 1010 Background: Current practice is to perform a completion axillary
lymph node dissection (ALND) for breast cancer (BC) patients with tumor-positive sentinel …

Abstract P1-01-09: Which nomograms may be the best for predicting nonsentinel lymph node metastasis in breast cancer patients: a meta-analysis.

K Chen, L Jin, L Zhu, Q Shan, F Su - Cancer Research, 2012 - AACR
Background: Axillary lymph node dissection (ALND) is the standard treatment for breast
cancer patients with positive sentinel lymph nodes (SLNs). Several nomograms were …

Validation of breast cancer models for predicting the nonsentinel lymph node metastasis after a positive sentinel lymph node biopsy in a Chinese population

P Wu, K Zhao, Y Liang, W Ye, Z Liu… - Technology in Cancer …, 2018 - journals.sagepub.com
Objectives: Over the years, completion axillary lymph node dissection is recommended for
the patients with breast cancer if sentinel lymph node metastasis is found. However, not all …

Applicability of two different validated models to predict axillary non-sentinel lymph node status by sentinel node biopsy in a single Italian center

S Bertozzi, AP Londero, F Giacomuzzi, V Angione… - Breast Cancer, 2015 - Springer
Background The necessity of complete axillary lymph node dissection (CALND) after
sentinel lymph node biopsy (SLNB) for women with sentinel lymph node metastases is a …

Independent risk factors for axillary lymph node metastasis in breast cancer patients with one or two positive sentinel lymph nodes

W Zhang, J Xu, K Wang, XJ Tang, H Liang, JJ He - BMC Women's Health, 2020 - Springer
Background The benefit of axillary lymph node dissection (ALND) in breast cancer patients
with one or two positive sentinel lymph nodes (SLNs) remains inconclusive. The purpose of …

[HTML][HTML] An exploratory study of whether axillary lymph node dissection can be avoided in breast cancer patients with positive lymph nodes

F Ren, C Yang, J Liu, K Feng, Q Shang… - Translational Cancer …, 2024 - ncbi.nlm.nih.gov
Background Breast cancer patients with positive axillary lymph nodes usually require
axillary lymph node dissection (ALND), with many postoperative complications, such as …